BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11594573)

  • 1. Apoptosis and cutaneous T cell lymphoma.
    Kacinski BM; Flick M
    Ann N Y Acad Sci; 2001 Sep; 941():194-9. PubMed ID: 11594573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proapoptotic and antiapoptotic markers in cutaneous T-cell lymphoma skin infiltrates and lymphomatoid papulosis.
    Nevala H; Karenko L; Vakeva L; Ranki A
    Br J Dermatol; 2001 Dec; 145(6):928-37. PubMed ID: 11899146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of cutaneous T-cell lymphomas].
    Rappersberger K; Ortel B; Forstinger C; Wolff K
    Wien Klin Wochenschr; 1994; 106(10):300-8. PubMed ID: 8053197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic alternatives in cutaneous T-cell lymphoma.
    Holloway KB; Flowers FP; Ramos-Caro FA
    J Am Acad Dermatol; 1992 Sep; 27(3):367-78. PubMed ID: 1383293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible resistance to apoptosis in cutaneous T cell lymphoma.
    Meech SJ; Edelson R; Walsh P; Norris DA; Duke RC
    Ann N Y Acad Sci; 2001 Sep; 941():46-58. PubMed ID: 11594582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of refractory early-stage cutaneous T-cell lymphoma.
    Huber MA; Staib G; Pehamberger H; Scharffetter-Kochanek K
    Am J Clin Dermatol; 2006; 7(3):155-69. PubMed ID: 16734503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of cutaneous T cell lymphoma: current status and future directions.
    Apisarnthanarax N; Talpur R; Duvic M
    Am J Clin Dermatol; 2002; 3(3):193-215. PubMed ID: 11978140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation.
    Licata AG; Wilson LD; Braverman IM; Feldman AM; Kacinski BM
    Arch Dermatol; 1995 Apr; 131(4):432-5. PubMed ID: 7726585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous T cell lymphoma: update on treatment.
    Wollina U
    Int J Dermatol; 2012 Sep; 51(9):1019-36. PubMed ID: 22909354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bexarotene gel: a new skin-directed treatment option for cutaneous T-cell lymphomas.
    Martin AG
    J Drugs Dermatol; 2003 Apr; 2(2):155-67. PubMed ID: 12852367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic therapy of cutaneous T-cell lymphoma (CTCL).
    Alpdogan O; Kartan S; Johnson W; Sokol K; Porcu P
    Chin Clin Oncol; 2019 Feb; 8(1):10. PubMed ID: 30818958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous T-cell lymphoma/leukemia.
    Siegel RS; Kuzel TM
    Curr Treat Options Oncol; 2000 Apr; 1(1):43-50. PubMed ID: 12057060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic approaches in cutaneous lymphoma.
    Jörg B; Kerl H; Thiers BH; Bröcker EB; Burg G
    Dermatol Clin; 1994 Apr; 12(2):433-41. PubMed ID: 8045054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future perspectives in the treatment of cutaneous T-cell lymphoma (CTCL).
    Dummer R
    Semin Oncol; 2006 Feb; 33(1 Suppl 3):S33-6. PubMed ID: 16516674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of phototherapy in cutaneous T-cell lymphoma.
    Pothiawala SZ; Baldwin BT; Cherpelis BS; Lien MH; Fenske NA
    J Drugs Dermatol; 2010 Jul; 9(7):764-72. PubMed ID: 20677530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the skin microbiome in cutaneous T-cell lymphoma delays tumour growth and increases survival in the murine EL4 model.
    Dey S; Vieyra-Garcia PA; Joshi AA; Trajanoski S; Wolf P
    Front Immunol; 2024; 15():1255859. PubMed ID: 38646524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current therapy concepts in cutaneous T-cell lymphomas].
    Nestle FO; Häffner AC; Schmid MH; Dummer R; Burg G
    Schweiz Med Wochenschr; 1997 Feb; 127(8):311-20. PubMed ID: 9157537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoids Bias Integrin Expression and Function in Cutaneous T-Cell Lymphoma.
    Wang L; DeMarco SS; Chen J; Phillips CM; Bridges LC
    J Invest Dermatol; 2015 Aug; 135(8):2102-2108. PubMed ID: 25826424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.